rapiplex a rapid multiplex immunoassay platform for
play

RapiPlex : A Rapid, Multiplex, Immunoassay platform for universal - PowerPoint PPT Presentation

+ RapiPlex : A Rapid, Multiplex, Immunoassay platform for universal application at the Point of Care June 2013 RapiPlex: Introduction + + Unique wholly owned intellectual property + Up to 12 analyte Multiplex + Quantitative and/or Qualitative +


  1. + RapiPlex : A Rapid, Multiplex, Immunoassay platform for universal application at the Point of Care June 2013

  2. RapiPlex: Introduction + + Unique wholly owned intellectual property + Up to 12 analyte Multiplex + Quantitative and/or Qualitative + Simple Intuitive User Interface + Versatility, Portability and Ease of Use built in + M ultiple diagnostic applications + Low cost of goods 2

  3. Leadership Team + Greater than 100 years proven experience in the Diagnostics and Healthcare Industries: Jim Merselis CEO Niamh O ’ Luanaigh COO Shane Moynihan Head of Engineering Jim Walsh Executive Chairman Diarmuid Flavin BD Advisor 3

  4. Unmet need for a versatile universal application POC Platform + 5 patent families + FTO — Choate, Hall & Stewart (Boston) + Robust manufacturing processes IP Position + IVD materials + Up to 12 analytes Robust Multiplex simultaneously Manufacturing + All immunoassay formats + Compact reader footprint Convenient + Multiple biological samples RapiPlex + Add sample, wait, read & Versatile + Small & large sample sizes Compact + No maintenance (20 μ l to 1ml) + Patient records + Simple to use + Designed for CLIA waiver + Quantitative results Accurate Low Cost + Qualitative results + No visual interpretation + Volume-driven low cost per test Rapid + Integrated & Automated batch calibration & controls + Results in 5 to15 minutes 4

  5. Demonstrated validated assays on RapiPlex Cardiac Markers Drugs of Abuse + Test for the presence of an complex protein + Test for the presence of a small molecule + Sandwich assay format + Competitive assay format + Quantitative + Semi-quantitative / Qualitative + Whole blood/serum/plasma sample + Saliva & urine samples + Demonstrates 2 analyte multiplexing + Demonstrates 2 analyte multiplexing CRP Cocaine Amphetamime Myoglobin

  6. Biosensia Intellectual Property + + 5 patent applications Cartridge System Fluidics Overall Design of the Multiplex Cartridge Sampling Handling Methods Instrumentation + Nationalisation in EU, US, Japan, China, Australia & Ireland + FTO – Choate, Hall & Stewart – Boston

  7. RapiPlex: An Integrated sample to answer multi-faceted point of care platform + + A Portfolio of Innovative technologies integrated into one universal platform 1. Fluidics cartridge 2. Immunodiagnostic assays 3. Integrated fluorescent reader + The RapiPlex system can be adapted to accurately measure any immunologically active substance 7

  8. Self Contained Single Use Cartridge + + Integrated sample handling that simplifies user procedure + Multi channel configuration which facilitates testing across broad dynamic ranges + Each cartridge can house up to 12 test zones , detecting 1-12 Biomarkers from 1 Sample + User adds sample and ‘ walks away ’ . Whole blood, serum, plasma, saliva, urine, stool samples and milk verified on the platform + Cartridge dimension 2 ” x 2.9 ” x 0.3 ” (base) and 0.8 ” (top) + Low cost to manufacture and assemble 8

  9. Reader: User Friendly Operation, Designed for CLIA Waiver + + Universal reader for all assay cartridges + Simultaneous multiplex quantitative and/or qualitative analysis + Highly sensitive optical detection of fluorescence + Compact platform suitable for lab, clinical or field use + Portable – battery or mains power + Foolproof and failsafe automated operation + Intuitive software interface controls all aspects of the test, and requires only minimal intervention by user + Multiple connectivity options + Easy to use – insert cartridge and read 9

  10. Reader: Features + + Connectivity + Multiplex up to 6 channels + Simple automated work flow LAN for data transfers USB for data export and updates + Results presented as they occur Wi-Fi available Hard and soft copies Thermal transfer printer + Integrated cartridge bar code reader + On board data storage for > 5000 cartridge Lot specific calibration – lot and expiry scans + Optional wand bar code scanner + Field Updateable + Large color 7 ” touch screen + Software Controls Graphics, text and images possible Self check on start up Simple user interface Self testing & regulation during scan + Compact Form Factor – 12 ” x 9.5 ” x 6 ” Integrated error reporting and notification + Configurable to interface with LIMS Calibration Data & interval Multiple user levels 10

  11. RapiPlex: Graphic User Interface (selected screens) + 11

  12. RapiPlex: Graphic User Interface (selected screens) + + Screen colour design: GREY : Report or Prompt GREEN : Successful operation, attract attention (Warning 231) AMBER : Alert RED : Warning! + Cartoon Instruction Graphics Inform user of procedure QC Test Passed Please Remove Cartridge Screen formats 12

  13. How RapiPlex fulfills customer requirements + Point of Care Customer Requirement RapiPlex Good correlation of analytical results of a PoC with a lab system √ Analytical performance of a PoC system similar to lab system √ √ Whole blood as sample material (finger prick and venous) Fast Turn-Around-Time √ Small and large sample volume √ No system maintenance √ High operator convenience √ √ Simple Intuitive user interface Fool proof and failsafe operation √ 13

  14. Recent Publications & Press + + Featured in Clinical Laboratory News October 2012 + Featured in IVD Technology June/July 2012 + AACC Oak Ridge Conference ‘ Emerging Technologies for 21 st Century Clinical Diagnostics 2012 Poster 1 “ Evaluation of a multiplex drugs of abuse detection platform with integrated sample handling technologies ” Poster 2 “ RapiPlex a small volume whole blood quantitative microfluidic florescent point of care platform ” + Featured in Clinica Medtech Ventures April 2012 + Featured in as ‘ One to Watch ’ in Irish Times Innovation Magazine August 2011 ‘

  15. Summary + + Rapid, multiplexing, quantitative diagnostic platform + Versatile, easy to use and suitable for a use with a multitude of biological samples + Unique portfolio of IP + RapiPlex Platform is suited for application in a variety of growth POCT markets + Demonstrated expertise in the integration of fluidics, photonics and IVD assay ’ s + Strategic partnerships being sought to bring product to market

  16. Contact Details + James Merselis CEO Biosensia Limited NovaUCD Belfield Innovation Park UCD Belfield Dublin 4 Ireland James.merselis@biosensia.com www.biosensia.com + 35317163650 16

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend